Clinical Trial Update: A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01 Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg, and to Evaluate the Effect of Food on the Pharmacokinetics of DA-1229_01 in Healthy Male Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics of DA-1229_01 compared with evogliptin plus metformin XR, and examining the effect of food o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DA-1229_01 (DA-1229)
• Evogliptin (evogliptin)
• Metformin XR 1000 mg (metformin extended-release 1000 mg)

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED